7SK Acts as an Anti-tumor Factor in Tongue Squamous Cell Carcinoma

Bowen Zhang1,2, Sainan Min3, Qi Guo1,2

  • 1Department of Geriatrics, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Frontiers in Genetics
|April 19, 2021
PubMed

Insights

Non-coding RNA 7SK acts as a tumor suppressor in tongue squamous cell carcinoma (TSCC). Its down-regulation correlates with tumor size, and it potentially counteracts the pro-tumorigenic roles of FOXJ3 and THRA.

Area of Science:

  • Molecular Biology
  • Oncology
  • Non-coding RNA Research

Background:

  • Non-coding RNA 7SK's role in transcription is known, but its function in cancer remains unclear.
  • Understanding 7SK's mechanisms in cancer is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the biological function and mechanism of 7SK in tongue squamous cell carcinoma (TSCC).
  • To identify genes regulated by 7SK and potential interacting transcription factors in TSCC.

Main Methods:

  • Analysis of 7SK expression in TSCC patient samples.
  • Cell-based assays, including migration assays and xenograft mouse models.
  • RNA-sequencing (RNA-Seq) after 7SK knockdown combined with publicly available ChIRP-seq data.
  • Motif analysis to identify transcription factor binding sites.

Main Results:

  • 7SK is down-regulated in TSCC and functions as a tumor suppressor.
  • 7SK expression negatively correlates with tumor size in TSCC patients.
  • Identified 27 7SK-regulated genes involved in tumor regulation, enriched for transcription factors FOXJ3 and THRA.
  • FOXJ3 and THRA promote TSCC cell migration and oppositely regulate 12 genes compared to 7SK.

Conclusions:

  • 7SK acts as an antitumor factor in tongue squamous cell carcinoma.
  • FOXJ3 and THRA may play a role in promoting TSCC progression, potentially through mechanisms counteracted by 7SK.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K